Google
AUPH — AURINIA PHARMACEUTICALS INC (Healthcare >> Biotechnology)
AUPH FAQ
What is AUPH's P/E ratio?
AURINIA PHARMACEUTICALS INC (AUPH) currently trades at a P/E ratio of 6.64.
What is AUPH's ROE?
AURINIA PHARMACEUTICALS INC reports a Return on Equity (ROE) of 52.54%.
What is AUPH's dividend yield?
AURINIA PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is AUPH's Deepscope Quality Score?
Deepscope rates AUPH's overall financial quality at 100 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy AUPH?
Deepscope's AI Timing Score for AUPH is 71 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does AUPH belong to?
AURINIA PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 15.67
Price
0.28
(1.82%)
Day Change
|
|
|---|
AUPH Chất lượng tổng thể của cố phiếu Xuất sắc ( Chất lượng = 100) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Excellent
- Reason
-
Sức khỏe tài chính của công ty Xuất sắc từ hầu hết các chỉ số chất lượng
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Khá , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Tốt , ...
| Yếu tố Chất lượng |
|
64% |
| In Recommendations? | In "Invest - GROWTH" Section |
| Select Rate | 1.69 From 30 days period |
| Watch Rate | 2.49 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
87
GOOD
|
| Magic Formula Rank by ROE |
87
GOOD
|
| Magic Formula Rank by ROIC |
142
|
| Price | 15.67 |
| PBV / Sector |
3.49 / 4.48
|
| Earning Per Share | 2.36 |
| PE / Sector |
6.64 / 16.68
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
20.43 M
GREAT
|
| Average 1W Daily Value |
18.59 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
72% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-04 09:23:38 |
| Symbol | AUPH |
| Name | AURINIA PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 128.60 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,979.18 / 8,483.11 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6
Phone: 250 744 2487
Website: https://www.auriniapharma.com
Employees: 128
Sector: Healthcare >> Biotechnology
Description: Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
